|
Quotes & Info
|
| ARRY > SEC Filings for ARRY > Form 8-K on 6-Nov-2012 | All Recent SEC Filings |
6-Nov-2012
Other Events, Financial Statements and Exhibits
On November 6, 2012, Array BioPharma issued a press release announcing that that data will be presented on drug candidate, ARRY-797, a p38 inhibitor at the 2012 American College of Rheumatology (ACR) Annual Meeting in Washington, D.C.
A copy of the press release is attached to this Form 8-K as Exhibit 99.1 and incorporated herein by reference.
(d) Exhibits
Exhibit No. Description
99.1 Press Release announcing presentation of clinical data at the 2012
ACR Meeting on ARRY-797, a p38 inhibitor
|
|
|